BLB is a contract research organization that aims to contribute with pharmaceutical partners to ultimately accelerate the development of new treatments for patients with liver disease.
BLB aims at providing superior quality research services and consulting in the fields of Hepatology and Toxicology. We combine exclusive cutting-edge technology with reliable traditional models that altogether permits high-value characterization of new chemical entities.
In BLB we truly believe that refinement of pre-clinical research, by using smarter experimental models that closer reflect patients pathophysiology, is the only way to shorten the bridge between bench work and clinical practice.
We are supported by the IDIBAPS Biomedical Research Institute & the CaixaImpulse bioentrepreneurship program, allowing us to grow within an environment of excellence in business & innovation.
We are innovative, passionate and scientifically curious.
We prioritize rigorousness and integrity.
We listen our customers, so we provide the best solution for their enquiries.
We are committed with our community & the environment.